Dark

INTS
Intensity Therapeutics, Inc. Common stock
stock NASDAQ

At Close

Apr 8, 2026 3:59:30 PM EDT

5.48USD+4.381%(+0.23)36,444

0.00Bid 0.00Ask 0.00Spread

Pre-market

Apr 9, 2026 8:22:30 AM EDT

5.74USD+4.364%(+0.24)230

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

13.72M

Industry

Biotechnology

Next Earnings

May 12, 2026 (33d)

Last Split

Feb 19, 20261for25reverse

INTS Stats

Avg. Vol. 10 Day

23,736

Avg. Vol. 30 Day

37,958

Market Cap

13,718,797

Shares Out.

2,540,518

On/Off Exchange

47%/53%

6 Month Beta

-2.98

1 Year Beta

-1.24

2 Year Beta

-0.47

3 Year Beta

-0.30

52 Week Low

4.63

52 Week High

50.00

SMA50

7.34

SMA200

8.40

1 Week

-5.09%

1 Month

-30.50%

3 Month

-50.24%

6 Month

-24.21%

1 Year

-89.04%

2 Year

-95.49%

Profile

intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company's technology and products.

INTS Stock Summary

Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) stock price today is $5.48, and today's volume is 36,444. INTS is up 4.381% today. The 30 day average volume is 37,958. INTS market cap is 13.72M with 2,540,518 shares outstanding.

.dark-mode .tPb8H6{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .tPb8H6{ color: #333333; background-color: white; border: 2px solid #333333; }INTSIntensity Therapeutics, Inc. Common stockstock NASDAQ

INTS Stock Summary

INTS
Intensity Therapeutics, Inc. Common stock
stock NASDAQ